Case Studies
Novel BRAF Inhibitors
In 2002 the ICR began a drug discovery programme funded by The Wellcome Trust, to develop novel inhibitors of the enzyme BRAF, mutations in the B-RAF gene.
3D Net Perfusion
Biotronics3D has worked with the ICR to develop and launch new software which could significantly improve the accuracy of Magnetic Resonance Imaging (MRI) analysis.
